Early Diabetes Resolution After Weight Loss Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00790309 |
Recruitment Status :
Completed
First Posted : November 13, 2008
Last Update Posted : April 21, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Obesity Diabetes | Procedure: Weight loss surgery Procedure: Laparoscopic abdominal surgeries |
Study Type : | Observational |
Actual Enrollment : | 75 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Hormonal and Inflammatory Parameters Affecting Early Diabetes Resolution Following Weight Loss Surgery |
Study Start Date : | December 2008 |
Actual Primary Completion Date : | February 2017 |
Actual Study Completion Date : | February 2017 |

Group/Cohort | Intervention/treatment |
---|---|
Weight loss surgery
This group will be comprised of people having weight loss surgery: Roux-en Y gastric bypass, vertical sleeve gastrectomy, or adjustable gastric banding
|
Procedure: Weight loss surgery
Weight loss surgery |
Abdominal surgery
This group will be comprised of people having abdominal surgeries such as nissen fundoplication or cholecystectomy.
|
Procedure: Laparoscopic abdominal surgeries
laparoscopic abdominal surgeries |
Lean
This group will be comprised of normal weight healthy volunteers.
|
- Determine to what extent improvements in glycemic control can be attributed to caloric restriction after weight loss surgery [ Time Frame: 10 days post-op ]
- Determine changes in inflammatory markers after weight loss surgery [ Time Frame: 10 days post-op ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria for surgery groups:
- BMI of 30 kg/m2 or higher
- Ages 18-65
- History of impaired glucose tolerance or T2DM
Inclusion Criteria for normal weight group:
- BMI of 30 kg/m2 or lower
- Ages 18-65
Exclusion Criteria:
- Development of an intercurrent infection
- Prior gastric, duodenal, proximal jejunal surgery or pancreas resection
- Current use of thiazolidinediones
- Current use of dipeptidyl peptidase-IV inhibitors (e.g., sitagliptin) or glucagon-like peptide-1 analogs (e.g., exenatide)
- Any condition felt by the PI or co-investigators to interfere with ability to complete the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00790309
Principal Investigator: | Naji Abumrad, MD | Vanderbilt University Medical Center |
Responsible Party: | Naji Abumrad, Chairman, Department of Surgery, Vanderbilt University Medical Center |
ClinicalTrials.gov Identifier: | NCT00790309 |
Other Study ID Numbers: |
NNA-Early DM Resolution |
First Posted: | November 13, 2008 Key Record Dates |
Last Update Posted: | April 21, 2017 |
Last Verified: | April 2017 |
Obesity Diabetes Bariatric surgery |
Diabetes Mellitus Weight Loss Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Body Weight Body Weight Changes |